Melanie Unangst is a Orefield, Pennsylvania based counselor who is specialized as Addiction (Substance Use Disorder) Counselor. Her current practice location is 2970 Corporate Ct, Orefield. Patients can book an appointment with her at 610-481-0444.
Melanie Unangst is a licensed mental health therapist who help individuals struggling with addiction of alcohol, drug, or other substance use disorder. She helps her clients by manage and overcome the psychological, emotional, and behavioral challenges related to substance use. Counselors also work closely with families and support systems to help them better understand their loved one’s illness. SUD counselors help to promote long-term sobriety, emotional stability, and overall mental wellness for both the individual and their family.
Complete Profile:
Melanie Unangst speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1790302230
NPI Enumeration Date:
01 Jul, 2020
NPI Last Update On:
01 Jul, 2020
Other Medical Identifiers:
Other legacy medical identifiers associated with Melanie Unangst such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
00
Medicaid
Pennsylvania
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2970 Corporate Ct, Orefield, Pennsylvania
Zip:
18069-3158
Phone Number:
610-481-0444
Patients can reach Melanie Unangst at 2970 Corporate Ct, Orefield, Pennsylvania or can call to book an appointment on 610-481-0444. *Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.